After months of rumors and speculation, Thermo Fisher Scientific this week announced its plans to buy Life Technologies for $13.6 billion in a deal expected to be completed in early 2014.

Speaking on a conference call immediately after the agreement was announced, Thermo Fisher officials said they expect the next-generation sequencing business to be a primary growth driver for Life Tech and exceed the growth rate for the rest of the acquired company.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.